<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Efficacy of weekly infusions of alpha-1 antitrypsin</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Efficacy of weekly infusions of alpha-1 antitrypsin</h1>
<div class="graphic"><div class="figure"><div class="ttl">Efficacy of weekly infusions of alpha-1 antitrypsin</div><div class="cntnt"><img src="data:png;base64,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"/></div><div class="graphic_lgnd">Serum alpha-1 antitrypsin (AAT) levels by immunodiffusion after once weekly administration of 60 mg/kg of active AAT to patients with the ZZ homozygous form of AAT deficiency. The dashed line represents the protective threshold. Weekly infusions (arrows) maintained the serum A1AT levels above this threshold. Values are in commercial standard units of mg/dL; the true standard levels in µmol/L can be estimated by dividing the immunodiffusion value by 7.3.</div><div class="graphic_reference">Redrawn from Hubbard RC, Crystal RG. Am J Med 1988; 84(Suppl 6A):52.</div><div id="graphicVersion">Graphic 68873 Version 2.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
